Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Interviews as Topic × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 10 Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 7 Lung Neoplasms 5 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Malignant Solid Neoplasm 3 Obesity-Related Malignant Neoplasm 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Incontinence 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Motor Activity 1 Mental Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Laryngeal Diseases 1

Interventions

Paclitaxel 5 Bevacizumab 5 Carboplatin 4 mirvetuximab soravtansine 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Hyperthermic Intraperitoneal Chemotherapy 2 trastuzumab deruxtecan 1 rucaparib 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 niraparib 1 isoquercitrin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 Topotecan 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Pharmaceutical Preparations 1 Nutrition Assessment 1 Nivolumab 1 Neoadjuvant Therapy 1 Injections 1 Immunotherapy, Adoptive 1 Glucose 1 GEN-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡